Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

RGS9 modulates dopamine signaling in the basal ganglia.

Rahman Z, Schwarz J, Gold SJ, Zachariou V, Wein MN, Choi KH, Kovoor A, Chen CK, DiLeone RJ, Schwarz SC, Selley DE, Sim-Selley LJ, Barrot M, Luedtke RR, Self D, Neve RL, Lester HA, Simon MI, Nestler EJ.

Neuron. 2003 Jun 19;38(6):941-52.

2.

D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways.

Kovoor A, Seyffarth P, Ebert J, Barghshoon S, Chen CK, Schwarz S, Axelrod JD, Cheyette BN, Simon MI, Lester HA, Schwarz J.

J Neurosci. 2005 Feb 23;25(8):2157-65.

4.

Measuring the modulatory effects of RGS proteins on GIRK channels.

Doupnik CA, Jaén C, Zhang Q.

Methods Enzymol. 2004;389:131-54. Review.

PMID:
15313564
5.

RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease.

Gold SJ, Hoang CV, Potts BW, Porras G, Pioli E, Kim KW, Nadjar A, Qin C, LaHoste GJ, Li Q, Bioulac BH, Waugh JL, Gurevich E, Neve RL, Bezard E.

J Neurosci. 2007 Dec 26;27(52):14338-48.

6.

D2 dopamine receptor activation of potassium channels is selectively decoupled by Galpha-specific GoLoco motif peptides.

Webb CK, McCudden CR, Willard FS, Kimple RJ, Siderovski DP, Oxford GS.

J Neurochem. 2005 Mar;92(6):1408-18.

7.

Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex.

Maple AM, Perna MK, Parlaman JP, Stanwood GD, Brown RW.

Eur J Neurosci. 2007 Nov;26(9):2532-8. Epub 2007 Oct 23.

PMID:
17970732
8.

Evidence of increased dopamine receptor signaling in food-restricted rats.

Carr KD, Tsimberg Y, Berman Y, Yamamoto N.

Neuroscience. 2003;119(4):1157-67.

PMID:
12831870
9.
10.
11.

Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice.

Gainetdinov RR, Bohn LM, Sotnikova TD, Cyr M, Laakso A, Macrae AD, Torres GE, Kim KM, Lefkowitz RJ, Caron MG, Premont RT.

Neuron. 2003 Apr 24;38(2):291-303.

12.

Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A(2A) adenosine receptors.

Chen JF, Beilstein M, Xu YH, Turner TJ, Moratalla R, Standaert DG, Aloyo VJ, Fink JS, Schwarzschild MA.

Neuroscience. 2000;97(1):195-204.

PMID:
10771351
13.

Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum.

Hervé D, Le Moine C, Corvol JC, Belluscio L, Ledent C, Fienberg AA, Jaber M, Studler JM, Girault JA.

J Neurosci. 2001 Jun 15;21(12):4390-9.

14.

Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.

Broderick PA, Hope O, Okonji C, Rahni DN, Zhou Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):157-71.

PMID:
14687870
15.

Co-expression of Gbeta5 enhances the function of two Ggamma subunit-like domain-containing regulators of G protein signaling proteins.

Kovoor A, Chen CK, He W, Wensel TG, Simon MI, Lester HA.

J Biol Chem. 2000 Feb 4;275(5):3397-402.

16.

RGS9-2 mediates specific inhibition of agonist-induced internalization of D2-dopamine receptors.

Celver J, Sharma M, Kovoor A.

J Neurochem. 2010 Aug;114(3):739-49. doi: 10.1111/j.1471-4159.2010.06805.x. Epub 2010 May 8.

17.

Estrogen modulates RGS9 expression in the nucleus accumbens.

Sharifi JL, Brady DL, Koenig JI.

Neuroreport. 2004 Oct 25;15(15):2433-6.

PMID:
15640770
20.

Phosphorylation and nuclear translocation of a regulator of G protein signaling (RGS10).

Burgon PG, Lee WL, Nixon AB, Peralta EG, Casey PJ.

J Biol Chem. 2001 Aug 31;276(35):32828-34. Epub 2001 Jul 6.

Items per page

Supplemental Content

Write to the Help Desk